{
  "author": {
    "name": "Rachel E Lusk Klebanoff",
    "webUrl": "/author/profile/rachel-e-lusk-klebanoff/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 4,
    "social": [],
    "articles": [
      {
        "uri": "/2021/12/23/surprise-billing-to-end-january-2022-with-the-no-surprises-act-412-124756/",
        "title": "Getting ready for an end to surprise billing",
        "byline": "Vasilios J. Kalogredis and Rachel E. (Lusk) Klebanoff",
        "kicker": "Expert Opinion",
        "prettyDate": "December 23, 2021",
        "timeToRead": "7 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/11/08-medical-bill.jpg",
          "width": "619",
          "height": "408"
        },
        "authors": [
          {
            "webUrl": "/author/profile/vasilios-j-kalogredis/",
            "name": "Vasilios J. Kalogredis"
          },
          {
            "webUrl": "/author/profile/rachel-e-lusk-klebanoff/",
            "name": "Rachel E. (Lusk) Klebanoff"
          }
        ],
        "kickerNode": [
          {
            "uri": "/expert-opinion/",
            "sectionName": "Expert Opinion"
          }
        ],
        "summary": "The No Surprises Act is a complicated statute, and many details regarding how it will be applied and enforced are still forthcoming.",
        "body": null
      },
      {
        "uri": "/2021/10/08/biden-issues-executive-order-targeting-noncompete-agreements-412-122199/",
        "title": "Biden targets noncompete agreements with new EO",
        "byline": "Vasilios J. Kalogredis and Rachel E. (Lusk) Klebanoff",
        "kicker": "News",
        "prettyDate": "October 08, 2021",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/SignContract.jpg",
          "width": "600",
          "height": "400"
        },
        "authors": [
          {
            "webUrl": "/author/profile/vasilios-j-kalogredis/",
            "name": "Vasilios J. Kalogredis"
          },
          {
            "webUrl": "/author/profile/rachel-e-lusk-klebanoff/",
            "name": "Rachel E. (Lusk) Klebanoff"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "The order represents a multipronged approach to encouraging greater competition and economic growth by making it easier for workers to change jobs.",
        "body": null
      },
      {
        "uri": "/2021/03/01/oig-oks-gift-card-offers-to-motivate-patients-to-attend-preventative-appointments-412-112360/",
        "title": "Incentivizing patients to attend preventative care appointments: What the OIG says",
        "byline": "Vasilios J. Kalogredis and Rachel E. (Lusk) Klebanoff",
        "kicker": "Expert Opinion",
        "prettyDate": "March 01, 2021",
        "timeToRead": "8 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/04/09Rewards.jpg",
          "width": "616",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/vasilios-j-kalogredis/",
            "name": "Vasilios J. Kalogredis"
          },
          {
            "webUrl": "/author/profile/rachel-e-lusk-klebanoff/",
            "name": "Rachel E. (Lusk) Klebanoff"
          }
        ],
        "kickerNode": [
          {
            "uri": "/expert-opinion/",
            "sectionName": "Expert Opinion"
          }
        ],
        "summary": "Those considering the best way to incentivize care should think critically about the structure of any programs and the types of incentives they provide.",
        "body": null
      },
      {
        "uri": "/2020/08/05/novartis-agrees-to-pay-678m-for-illegal-kickbacks-in-sham-speaker-scheme-412-102065/",
        "title": "Novartis to pay $678M for illegal kickbacks in 'sham' speaker scheme",
        "byline": "Vasilios J. Kalogredis and Rachel E. Lusk Klebanoff",
        "kicker": "News",
        "prettyDate": "August 05, 2020",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/11/NovartisShutterstock.jpg",
          "width": "625",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/vasilios-j-kalogredis/",
            "name": "Vasilios J. Kalogredis"
          },
          {
            "webUrl": "/author/profile/rachel-e-lusk-klebanoff/",
            "name": "Rachel E. Lusk Klebanoff"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "In one instance, a doctor who prescribed Novartis drugs 8,000 times allegedly received $320,000 in fees for dubious engagements.",
        "body": null
      }
    ]
  }
}